VANGUARD GROUP INC - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 51 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,766,343
-32.5%
1,226,858
+0.2%
0.00%
Q2 2023$7,065,025
-2.8%
1,224,441
+9.5%
0.00%
Q1 2023$7,265,551
+158.3%
1,117,777
+9.3%
0.00%
Q4 2022$2,812,668
-4.8%
1,022,788
+1.0%
0.00%
Q3 2022$2,956,000
+52.0%
1,012,5960.0%0.00%
Q2 2022$1,945,000
-65.4%
1,012,596
+46.3%
0.00%
Q1 2022$5,614,000
-11.5%
692,159
-0.0%
0.00%
Q4 2021$6,340,000
-26.7%
692,195
+0.0%
0.00%
Q3 2021$8,652,000
+11.3%
692,176
+0.6%
0.00%
Q2 2021$7,772,000
-27.8%
687,811
-3.2%
0.00%
Q1 2021$10,766,000
+57.0%
710,683
+19.3%
0.00%
Q4 2020$6,856,000
+51.1%
595,652
+1.6%
0.00%
Q3 2020$4,538,000
-30.8%
586,339
-1.5%
0.00%
Q2 2020$6,557,000
+3.5%
595,498
+2.8%
0.00%
Q1 2020$6,335,000
-30.4%
579,485
+1.2%
0.00%
Q4 2019$9,096,000
+13.4%
572,438
+5.3%
0.00%
Q3 2019$8,024,000
+51.1%
543,639
+18.9%
0.00%
Q2 2019$5,312,000
+14.0%
457,103
+6.0%
0.00%
Q1 2019$4,661,000
+41.1%
431,245
+6.4%
0.00%
Q4 2018$3,303,000
-30.5%
405,242
+38.5%
0.00%
Q3 2018$4,753,000
+765.8%
292,489
+950.7%
0.00%
Q2 2018$549,00027,8380.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Altium Capital Management LP 256,244$3,203,0000.84%
Perceptive Advisors 3,610,412$45,130,0000.66%
Orbimed Advisors 1,479,733$18,497,0000.20%
Fosun International Ltd 282,408$3,530,0000.18%
KORNITZER CAPITAL MANAGEMENT INC /KS 728,236$9,103,0000.14%
SteelPeak Wealth, LLC 133,161$1,665,0000.11%
HighVista Strategies LLC 10,944$137,0000.09%
Capital Investment Advisory Services, LLC 15,125$189,0000.02%
MML INVESTORS SERVICES, LLC 44,875$561,0000.00%
BECK MACK & OLIVER LLC 10,000$125,0000.00%
View complete list of VERRICA PHARMACEUTICALS INC shareholders